TLR3 agonist improves survival to secondary pneumonia in a double injury model

Keyphrases

• Poly IC 100%
• Injury Model 100%
• TLR3 Agonist 100%
• Secondary Pneumonia 100%
• Cecal Ligation 80%
• Cecal Puncture 80%
• Lung 40%
• Pneumonia 40%
• Bronchoalveolar Lavage 40%
• Pseudomonas Aeruginosa (P. aeruginosa) 40%
• Toll-like Receptor 3 (TLR3) 40%
• Toll-like 20%
• Immune Response 20%
• Clinically Significant 20%
• Corrective 20%
• Sepsis 20%
• Lymphocyte Cell 20%
• Bacterial Infection 20%
• B6 Mice 20%
• Immune Regulation 20%
• Prophylactic Treatment 20%
• Intranasal 20%
• Phosphate-buffered Saline 20%
• Innate Cells 20%
• Lung Epithelial Cells 20%
• Acute Study 20%
• Cytokine Analysis 20%
• Immune Dysfunction 20%
• Antiviral Pathways 20%
• Colony Count 20%

Medicine and Dentistry

• Injury 100%
• Toll Like Receptor 3 100%
• Polyinosinic Polycytidylic Acid 100%
• Ligation 80%
• Puncture 80%
• Lung 60%
• Pseudomonas aeruginosa 40%
• Lavage 40%
• Cytokine 20%
• Immune Response 20%
• Epithelial Cell 20%
• Sepsis 20%
• Bacterial Infection 20%
• Prophylaxis 20%
• Antivirus Agent 20%
• Toll Like Receptor 20%
• Immunomodulation 20%
• Immunity 20%
• Mouse Study 20%
• Phosphate Buffered Saline 20%
• Immune Disorder 20%
• Lymphocyte 20%